Nexgel, Inc.NXGL
Price (close)
$0.26
Market cap
$2.6M
P/E
—
Revenue (TTM)
$12.1M
Net income
-$6.2M
Dividend yield
—
1-year total return
-89.1%
Net margin
-51.3%
Revenue growth
3.4%
Debt / equity
0.09x
What Nexgel, Inc. does.
water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug
delivery and cosmetics. We specialize in custom gels by capitalizing on proprietary manufacturing technologies. We distribute our products
as a contract manufacturer, supplying our gels to third parties who incorporate them into their own products. We also have a line of branded
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $674,000 | $1.6M | $2.0M | $4.1M | $8.7M | $11.4M |
| Net income | -$2.3M | -$4.3M | -$4.7M | -$3.2M | -$3.3M | -$3.0M |
| Free cash flow | -$2.1M | -$3.0M | -$3.1M | -$3.9M | -$4.3M | -$1.4M |
More on NXGL.
- Nexgel, Inc. summary
- Nexgel, Inc. financial statements
- Nexgel, Inc. key metrics
- Nexgel, Inc. health scores and style box
- Nexgel, Inc. earnings
- Nexgel, Inc. dividends
- Nexgel, Inc. valuation
- Nexgel, Inc. ownership and insiders
- Nexgel, Inc. peers
Figures from Nexgel, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.